medreg+1 bhuva ecgs

159
Developing people for health and healthcare ECG workshop: the common and the dangerous Anish Bhuva Cardiology Academic Clinical Fellow The Heart Hospital

Upload: medreg1

Post on 02-Jun-2015

194 views

Category:

Health & Medicine


0 download

TRANSCRIPT

Page 1: MedReg+1 Bhuva ECGs

Developing people for health and healthcare

ECG workshop: the common and the dangerous

Anish BhuvaCardiology Academic Clinical FellowThe Heart Hospital

Page 2: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Objectives

Acute coronary syndroms

Risk stratification

Management

MimicsSVTAFBroad complex tachycardia

Page 3: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Format

3 ECG Booklets

ST segment elevation

NSTEACs

Arrhythmia

Brief small group discussion of each booklet followed by answers

Page 4: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Pick up booklet 1

Page 5: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Booklet 1

Decide whether to

Blue light, this is a primary!

Leave until the post-take round

Observe for now

5 minutes for 10 scenarios

Page 6: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

STEACS: diagnosis

Page 7: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Inferior STEMI

Blue light to nearest PCI centre! Scenario 1

Page 8: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Page 9: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Inferior STEMI

20% associated with CHB

Stablise prior to transfer!

Narrow QRS, Rate > 50 is safer

Will one dose atropine last an LAS transfer?Isoprenaline infusionTemporary pace + escort?

Page 10: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Page 11: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Anterior STEMI

Blue light to nearest PCI centre! Scenario 2

Page 12: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Medication in primary PCI

Page 13: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Page 14: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Novel antiplatelet agents

Clopidogrel 600mg:Better outcomes only in PCI OASIS 7Less ‘resistance’/ non responsiveness ISAR- CHOICE OASIS

7No excess hazard (with fibrinolysis)Improved pharmacokinetics ARMYDA-2

Ticagrelor 180mg loading: PLATOTicagrelor > ClopidogrelCI: moderate hepatic dysfunction, previous haemorrhagic stroke

Prasugrel TRITONCI: age >75; low body weight; previous TIA/Stroke

Page 15: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Admission ECG Scenario 3

Page 16: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

a)Blue light, this is a primary!b)Observec)Discharge

Page 17: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

a)Blue light, this is a primary!b)Observec)Discharge

Page 18: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Repeat at 20 minutes

Page 19: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Scenario 4

Page 20: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

a)Blue light, this is a primary!b)Observec)Discharge

Page 21: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

a)Blue light, this is a primary!b)Observec)Discharge

Page 22: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

High take off

Scenario 4

Page 23: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

High take off

This patient was taken to the cath lab

Normal coronaries

Fixed ECG changes on repeat at 24 hours

Page 24: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Scenario 5

Page 25: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

a)Blue light, this is a primary!b)Observec)Discharge

Page 26: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

a)Blue light, this is a primary!b)Observec)Discharge

Page 27: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Early repolarisation

Page 28: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Page 29: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Early repolarisation

1. J point elevation + concave ST elevation2. Peaked asymmetrical T waves with steeper descending element than ascending

Also:1. Variability with heart rate2. Young, male, Afro-Caribbean

History and clinical context (Pre test probability) important if unsure

(Provide copy of ECG on discharge)

Definition of Early Repolarization: A Tug of WarDerval et al Circulation 2011 Scenario 5

Page 30: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Scenario 6

Page 31: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

a)Blue light, this is a primary!b)Observec)Discharge

Page 32: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

a)Blue light, this is a primary!b)Observec)Discharge

Page 33: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Pericarditis

Page 34: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Page 35: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Scenario 9

Page 36: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Scenario 7

Page 37: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

a)Blue light, this is a primary!b)Observec)Discharge

Page 38: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

a)Blue light, this is a primary!b)Observec)Discharge

Page 39: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Scenario 7

LV Aneurysm

Page 40: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Page 41: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Scenario 8

Page 42: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

a)Blue light, this is a primary!b)Observec)Discharge

Page 43: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

a)Blue light, this is a primary!b)Observec)Discharge

Page 44: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Q wave infarction

Scenario 8

Page 45: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

“Pain was worst two hours ago”

Assume this was the index episode

Candidate for emergency reperfusion

Extent of R wave voltage

“No chest pain, but I am breathless”

Cardiogenic shock

Page 46: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Cardiogenic shock

Inotropes CASINOIABP

IABP- SHOCK IILVADReperfusion

SHOCK..ECMO

Is myocardium viable?• History• ECG• Echo• Clinical context

Escalate early: these are the difficult decisions balancing high risk and mortality

Page 47: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Scenario 10

Page 48: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

a)Blue light, this is a primary!b)Observec)Discharge

Page 49: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

a)Blue light, this is a primary!b)Observec)Discharge

Page 50: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Sgarbossa criteria

Look for concordant ST Elevation!

Sgarbossa et al Electrocardiographic diagnosis of evolving acute myocardialinfarction in the presence of left bundle-branch block. N Engl J Med 1996;334:481–487. 

Page 51: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Myth- busting

You can’t interpret a paced rhythm

Page 52: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Truth

You can observe for dynamic changes

Use Sgarbossa’s criteria

Page 53: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Pick up booklet 2

Page 54: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Practice scenarios

Decide on the important diagnostic features and key management steps in the next ECG booklet

5 minutes for 9 scenarios

Page 55: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

NSTEACS

Scenario 1

Page 56: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Would you:a) Discharge after 48 hours ACS Rx;b) Refer for angiography;c) Organise stress imaging.

Page 57: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

NSTEACS

Page 58: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Troponin

Page 59: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Cardiac troponin I (cTnI) levels in a healthy reference population and in an acute coronary syndrome (ACS) population.

Mahajan V S , and Jarolim P Circulation. 2011;124:2350-2354

Copyright © American Heart Association, Inc. All rights reserved.

Page 60: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

How to use hs-Trop

Diagnosis

>99th centile at 3hours: • Sensitivity = c. 99%

<99th centile at 3 hours:• NPV > 95%

Risk stratification

Any level of + troponin is associated with a poor prognosis

BUT we are now picking it up in patients without an acute coronary syndrome

Page 61: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

“When troponin was a lousy assay it was a great test, but now that it's becoming a

great assay, it's getting to be a lousy test.”

Jesse RL. On the relative value of an assay versus that of a test: a history of troponin for the diagnosis of myocardial infarction. J Am Coll Cardiol. 2010;55:2125–2128

Page 62: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

NSTEACS

Page 63: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Non ST Elevation Myocardial infarction

Page 64: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Page 65: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

NSTEACS

Page 66: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

50 year old femaleHR 75Moderate COPDTroponin riseSBP 120/80Creat 75No ST changes

Page 67: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Risk scores

Risk Stratification (for NSTEACS)

Other models:• TIMI• ACC/AHA

http://www.outcomes-umassmed.org/grace/acs_risk/acs_risk_content.html

…may help with triage for invasive management

Page 68: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

NICE: NSTEACS guidance

Page 69: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Risk scores

Risk Stratification (for NSTEACS)

Other models:• TIMI• ACC/AHA

http://www.outcomes-umassmed.org/grace/acs_risk/acs_risk_content.html

…may help with triage for invasive management

Page 70: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Would you:a) Discharge after 48 hours ACS Rx;b) Refer for angiography;c) Organise stress imaging.

Page 71: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Page 72: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Take home message

High sensitivity assays may give borderline false positive results

Risk scores are influenced by epidemiological as well as patient specific factors

Page 73: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Scenario 2

Page 74: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Would you:a) Discharge after 48 hours ACS Rx;b) Refer for angiography;c) Organise stress imaging.

Page 75: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Would you:a) Discharge after 48 hours ACS Rx;b) Refer for angiography;c) Organise stress imaging.

Page 76: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Page 77: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

ESC guidelines

Page 78: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Page 79: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Page 80: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Left main stem ischaemia

ST elevation in aVR onlyInfero-lateral ST depression

“Whilst this does not qualify for primary PCI this patient, I am worried that this is main stem ischaemia”

Page 81: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

S

Scenario 8

Page 82: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Page 83: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Page 84: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Would you:a) Discharge after 48 hours ACS Rx;b) Refer for angiography;c) Organise stress imaging.

Page 85: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Would you:a) Discharge after 48 hours ACS Rx;b) Refer for angiography;c) Organise stress imaging.

Page 86: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Wellen’s syndrome

Scenario 3

Page 87: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Wellen’s syndrome

Chest pain (often intermittent)

Characteristic ECG:

Anterior T wave inversion

Bifid T waves

Normal Trop/Mildly elevatedNo established infarction

A sign of impending LAD occlusion and requires urgent intervention

Page 88: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Scenario 4

Page 89: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Would you:a) Discharge after 48 hours ACS Rx;b) Refer for angiography;c) Organise stress imaging.

Page 90: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Would you:a) Discharge;b) Refer for angiography;c) Organise stress imaging.

Page 91: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

LVH + strain

Scenario 4

Page 92: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Scenario 5

Page 93: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Would you:a) Discharge after 48 hours ACS Rx;b) Refer for angiography;c) Organise stress imaging.

Page 94: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

HCM

Scenario 5

Page 95: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Page 96: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Would you:a) Discharge after 48 hours ACS Rx;b) Refer for angiography;c) Organise stress imaging.

Page 97: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Would you:a) Discharge after 48 hours ACS Rx;b) Refer for angiography;c) Organise stress imaging.

Page 98: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

RV infarction

Scenario 6

Page 99: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Life in the fast lane.com

Page 100: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

RV infarction

V1 ST elevation V2 ST depressionIII>II ST elevation

Page 101: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

RV infarction: management

Maintain RV pre loadReduce afterload Restore A-V synchrony

Avoid nitrates! Cautious ACEi introduction

Page 102: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Scenario 7

Page 103: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Would you:a) Discharge after 48 hours ACS Rx;b) Refer for angiography;c) Organise stress imaging.

Page 104: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

THIS IS A STEMI!

Page 105: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Posterior myocardial infarction

Scenario 7

Page 106: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Page 107: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Posterior infarction

This is a STEMI

Dominant R in V1/2Anterior ST depression with upright T waves

Diagnosis: V7-9

Page 108: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Pick up booklet 3

Page 109: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Arrhythmia management

5 minutesRead through the next few scenarios and come up with a diagnosis and

management

Page 110: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Page 111: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Would you:IV metoprololPO metoprololAmiodaroneFlecainide Shock

Page 112: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Acute control

Drug Time to rhythm control/hrs

Time to rate control/hrs

Chance of cardioversion

Metoprolol 5 mins 13%

Sotalol 10-15%

Digoxin 2-6 hours 5%

Verapamil 0.5 5 mins 6-14%

Flecainide 1 67-92% at 6hrs

Amiodarone 6-24 6-8 hours 40-60% at 24 hrs

MgSO4 5-15 mins OR 1.6 (1.07-2.4)

Expect 50% conversion at 15-120minutes ESC Guidelines: Atrial FibrillationBraunwald’s Heart DiseaseESC textbook of cardiology

Page 113: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Flecainide

Better than amiodarone for <24 hours duration of AF

Contraindicated in abnormal LV function and ischaemic heart disease

Risk of ‘paradoxical’ rate increase

Page 114: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Page 115: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Tip

Echo for LV function useful prior to giving flecainide

Page 116: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Page 117: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Would you:Urgent DCCVDCCV at 6 hoursVerapamilBetablockadeFlecainide

Page 118: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Would you:Urgent DCCVDCCV at 6 hoursVerapamilBetablockadeFlecainide

Page 119: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

SVT

Sinus tachycardiaAtrial tachycardiaAVNRTAVRTParoxysmal junctional tachycardia

Page 120: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

AVNRT

Page 121: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

AVNRT

Stepwise approach:VagalAdenosineVerapamil 5-10mg IV [successful in 2 minutes in 90%]Betablockade less used as less effective but fineDigoxin possible with repeat vagal maneuvresDCCV should be used over flecainide etc.

Page 122: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Page 123: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Would you:a) Adenosineb) DCCV c) Bisoprolold) Flecainide

Page 124: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Would you:a) Adenosineb) DCCV c) Bisoprolold) Flecainide

Page 125: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Atrial Flutter

Page 126: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Take home message

Easy to DCCV flutter (50J)Difficult to rate control

Page 127: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Page 128: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Broad complex tachycardia

If ischaemic heart disease, think:

VT

VT

VT

95% specificity

Page 129: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

VT storm

>3 episodes in 24 hours

Cf. Incessant VT

1 episode of hours duration

Page 130: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

VT storm

Treat cause

More likely due to scar substrate than acute ischaemia if monomorphicDrugsElectrolytesIschaemia

Page 131: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

VT storm

Betablockade

Single most effective treatmentAmiodarone

LignocaineSedation

Page 132: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Pacing and VT

Appropriate shocks:

Device action can promote cardiac dysfunction– > further arrhythmia

Inappropriate shocks:

Get a magnet [resus trolley]

Cause?• eg. Lead migration/fracture (effusion?)

Reprogramme/control SVT

Page 133: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Page 134: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

78 year old male. History 3 previous MI, NIDDM, BPH. He presents with syncope and subsequent head injury. Normal CT head.

Page 135: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Page 136: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Would you:AdmitOP follow upDischarge after observation

Page 137: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Would you:AdmitOP follow upDischarge after observation

Page 138: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Sinus bradycardia with VEQRS 120, Normal axis1st degree heart block

Page 139: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

ESC guidelines: syncope 2009

Page 140: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Page 141: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

How would you manage him?a) Ignoreb) Bisoprololc) Dual antiplatelet therapyd) Amiodarone

Page 142: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

NSVT

Can be found in structurally normal hearts

Ask yourself what is the cause

Page 143: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Post MI, Cardiomyopathy groups:

Suppression of ambient arrhythmia is not a therapeutic target

ACC/AHA/ESC 2006 guidelines for management of patients withventricular arrhythmias and the prevention of sudden cardiac death

Page 144: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

VT or not VT?

Page 145: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Page 146: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Page 147: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Page 148: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Page 149: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Three hundred and forty-eight VTs and 170 SVTs with aberrant conduction were included in the comparison: Brugada criteria.

Alzand B S , and Crijns H J Europace 2011;13:465-472

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2010. For permissions please email: [email protected].

Page 150: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

How to look with VT

Hx IHD (95% specificity)+ AVR (80% specificity)Capture beats [sinus beat]Fusion beats [hybrid complexes]Discordant P wavesConcordant complexes

Page 151: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Discordant QRS complexesNegative aVRBut…• Capture beats• Fusion beats

Page 152: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

+ AVRConcordant

Page 153: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

No positive criteria for VT• LBBB• Sharp initial downstroke

SVT + LBBB aberrancy?VT- not ruled out

Page 154: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Preexcited AF

Page 155: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Preexcited AF

AF in the context of an accessory pathway

Variable QRS length

High risk to degenerate into VF

AV Nodal agents contraindicated

Page 156: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Artefact

Page 157: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Summary

Identify high risk ACSInterpret ischaemic ECGsUnderstand pharmacokinetics on anti-arrhythmicsLook good identifying VT

Page 158: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Acknowledgement

Patients from UCLH and the Heart Hospital

Lifeinthefastlane.com

Page 159: MedReg+1 Bhuva ECGs

Developing people forhealth and healthcare

Thank you

[email protected]